GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Gross Profit

Tilray Brands (Tilray Brands) Gross Profit : $208.2 Mil (TTM As of Feb. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Gross Profit?

Tilray Brands's gross profit for the three months ended in Feb. 2024 was $49.4 Mil. Tilray Brands's gross profit for the trailing twelve months (TTM) ended in Feb. 2024 was $208.2 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Tilray Brands's gross profit for the three months ended in Feb. 2024 was $49.4 Mil. Tilray Brands's Revenue for the three months ended in Feb. 2024 was $188.3 Mil. Therefore, Tilray Brands's Gross Margin % for the quarter that ended in Feb. 2024 was 26.23%.

Tilray Brands had a gross margin of 26.23% for the quarter that ended in Feb. 2024 => Competition eroding margins

During the past 12 years, the highest Gross Margin % of Tilray Brands was 144.14%. The lowest was 18.59%. And the median was 24.27%.

Warning Sign:

Tilray Brands Inc gross margin has been in long-term decline. The average rate of decline per year is -21.7%.


Tilray Brands Gross Profit Historical Data

The historical data trend for Tilray Brands's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Gross Profit Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.51 96.05 123.18 116.82 146.96

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.70 67.16 44.20 47.41 49.40

Competitive Comparison of Tilray Brands's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Gross Profit distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Gross Profit falls into.



Tilray Brands Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Tilray Brands's Gross Profit for the fiscal year that ended in May. 2023 is calculated as

Gross Profit (A: May. 2023 )=Revenue - Cost of Goods Sold
=627.124 - 480.164
=147.0

Tilray Brands's Gross Profit for the quarter that ended in Feb. 2024 is calculated as

Gross Profit (Q: Feb. 2024 )=Revenue - Cost of Goods Sold
=188.34 - 138.944
=49.4

Gross Profit for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $208.2 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Tilray Brands's Gross Margin % for the quarter that ended in Feb. 2024 is calculated as

Gross Margin % (Q: Feb. 2024 )=Gross Profit (Q: Feb. 2024 ) / Revenue (Q: Feb. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=49.4 / 188.34
=26.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tilray Brands  (NAS:TLRY) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tilray Brands had a gross margin of 26.23% for the quarter that ended in Feb. 2024 => Competition eroding margins


Tilray Brands Gross Profit Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (Tilray Brands) Business Description

Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.
Executives
Denise M Faltischek officer: Chief Strategy Officer C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel officer: Global General Counsel EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon director, officer: President & CEO C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Carl A Merton officer: Chief Financial Officer C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Brendan Kennedy director 1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers officer: Head of Canada C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan director TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky director 55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin officer: Chief Operating Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck officer: Chief Financial Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp director 444 LENOX AVENUE, SOUTH ORANGE NJ 07079